Faculty Opinions recommendation of Natalizumab induction and maintenance therapy for Crohn's disease.
2018 ◽
Vol 12
(supplement_1)
◽
pp. S314-S314
Keyword(s):
2017 ◽
Vol 2
(4)
◽
pp. 228-235
◽
Keyword(s):
2012 ◽
Vol 51
(6)
◽
pp. 595-599
◽
2016 ◽
Vol 51
(9)
◽
pp. 1093-1099
◽
Keyword(s):
Keyword(s):